title: A case treated with nivolumab after small cell lung cancer transformation of mutant EGFR non-small cell lung cancer.
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: S
authors.initials: S
authors.lastname: Nishikawa
authors.affiliation: Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa.
authors.forename: Y
authors.initials: Y
authors.lastname: Tambo
authors.affiliation: Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Ninomiya
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: T
authors.initials: T
authors.lastname: Oguri
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: Y
authors.initials: Y
authors.lastname: Kawashima
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: N
authors.initials: N
authors.lastname: Takano
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: S
authors.initials: S
authors.lastname: Kitazono
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: F
authors.initials: F
authors.lastname: Ohyanagi
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: A
authors.initials: A
authors.lastname: Horiike
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
authors.forename: N
authors.initials: N
authors.lastname: Yanagitani
authors.affiliation: Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Ishikawa
authors.affiliation: Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo mnishio@jfcr.or.jp.
authors.forename: M
authors.initials: M
authors.lastname: Nishio
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D000077594:Nivolumab; D055752:Small Cell Lung Carcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077594:Nivolumab; C512478:EGFR protein, human; D066246:ErbB Receptors